Amorepacific Group has developed a chipless wireless electronic skin that accurately analyzes and measures skin conditions in collaboration with professor Kim Jeehwan of the Massachusetts Institute of Technology (MIT).
The technology, developed after four years of joint research, does away with the use of heavy equipment.
The scholarly publication Science reported the results of this breakthrough.
By making it simpler to identify the skin ailments of people who work in specialized surroundings while being exposed to cold, heat, or dryness, Amorepacific anticipates that this technology will aid in the development of customized functional cosmetics.
Major brands like Sulwhasoo from Amorepacific will leverage the technology developed from this study.
Clinical skin research demands the use of expensive diagnostic tools in addition to sustaining a constant temperature and humidity level.
As a result, there aren't many results from skin research that were obtained in unique circumstances.


Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Yes, government influences wages – but not just in the way you might think
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Parents abused by their children often suffer in silence – specialist therapy is helping them find a voice
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility 



